Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)

Clinical trial NCT05983471 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05983471
Sponsor: Melius Pharma AB
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Cough IPF Fibrotic Lung Disease Chronic Cough Coughing

Start date: 2024-04-01
Primary completion: 2025-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.